Galecto Stock Skyrockets 600% – Short Squeeze Mania or Biotech Breakthrough?
Galecto Inc. (NASDAQ: GLTO) shares soared over 600% in pre-market trading on Oct. 7, 2025, with more than 42 million shares traded despite no new company news. The stock, previously a low-float penny biotech, briefly touched $10 before retreating. Galecto has no revenue, heavy losses, and ended Q2 with $10.2 million in cash. Analysts remain cautious, citing high financial risk and limited coverage.